Question 1

Does Duquesne Family Office own ELVN stock?

Accepted Answer

No. Duquesne Family Office exited its ELVN (Enliven Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 947,405 shares worth $19.4M.

Question 2

How many shares of ELVN does Duquesne Family Office own?

Accepted Answer

None since Q4 2025, when Duquesne Family Office exited the position. Its Q3 2025 13F listed 947,405 shares worth $19.4M.

Question 3

What is Duquesne Family Office's ELVN position worth?

Accepted Answer

Duquesne Family Office's ELVN position was worth $19.4M in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Duquesne Family Office buying or selling ELVN?

Accepted Answer

In Q4 2025, Duquesne Family Office exited its entire ELVN position.

Question 5

When did Duquesne Family Office first buy ELVN?

Accepted Answer

Duquesne Family Office first reported ELVN in its Q2 2025 13F and listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$15.55	0
2025-Q3	Increased	947,405	+104.6%	$19.4M	0.5%	$20.30	55
2025-Q2	New	463,000	—	$9.3M	0.2%	$20.68	46